Skip to main content
. 2020 Jun 18;15(6):e0234508. doi: 10.1371/journal.pone.0234508

Table 2. Summary of serological and molecular diagnostic results for the 5 patients with neurological manifestations.

Patient ID Sample source No. of days of illness NS1 Antigen rapid test Viremia level by real time RT-PCR (log10copies/ml) Virus isolation DENV conventional RT-PCR NGS analysis IgM ratioa IgG titerb Type of infection Remark
1 252-Sc 3 + 5.7 + DENV-2 DENV-2 11.6 43,002 Sec recovery
252-Cd 5 ND 7.8 + DENV-2 DENV-2 3.2 3,666
2 257-S 5 + 8.9 + DENV-2 DENV-2 0.5 294 Pri death
257-C 5 + 8.3 + DENV-2 DENV-2 0.5 95
Brain tissue (autopsy) 7 DENV-2
3 256-S 5 + 6.7 + DENV-2 DENV-2 9.5 44,876 Sec recovery
256-C 5 ND 3.4 - - - 12.1 57,677
4 251-S 3 + 4.2 - - - 11.5 72,099 Sec recovery
251-C 3 ND 6.3 - - - 4.5 8,760
5 1354-S 10 - 3.6 - - - 11.8 60,405 Sec recovery
1354-C 10 - 3.9 - - - 2.2 16,183

ND: not done. Pri: primary infection. Sec: secondary infection.

a DENV IgM P/N ratio ≥ 2 considered as positive.

b DENV IgG titer ≥ 29,000 considered as secondary and < 29,000 as primary infection.

cS: serum

dC:CSF.